Seres Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $168.2M | $342.9M | $116.0M |
| FY2021 | $223.4M | $354.9M | $180.0M |
| FY2022 | $338.0M | $348.8M | $163.0M |
| FY2023 | $403.5M | $358.6M | $128.0M |
| FY2024 | $126.0M | $139.8M | $30.8M |